GST exemption on specified COVID medicines reduces state tax liability for listed therapeutic goods during the notified period. The notification uses powers under section 11 of the Maharashtra GST Act to exempt specified Chapter 30 pharmaceutical goods from State tax to the extent liability exceeds the amount calculated at the rates shown in the Table: Tocilizumab and Amphotericin B at Nil; other listed COVID-19 therapeutics at a reduced rate. The exemption applies to the State tax leviable under section 9 and is limited to the notified period from 1 October 2021 through 31 December 2021.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
GST exemption on specified COVID medicines reduces state tax liability for listed therapeutic goods during the notified period.
The notification uses powers under section 11 of the Maharashtra GST Act to exempt specified Chapter 30 pharmaceutical goods from State tax to the extent liability exceeds the amount calculated at the rates shown in the Table: Tocilizumab and Amphotericin B at Nil; other listed COVID-19 therapeutics at a reduced rate. The exemption applies to the State tax leviable under section 9 and is limited to the notified period from 1 October 2021 through 31 December 2021.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
Join Channel
TaxTMI 
